# Vancomycin Study in Multiple Sclerosis (MS)

> **NCT05539729** · PHASE1 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 12 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05539729
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-31
- **Primary completion:** 2026-03
- **Final completion:** 2026-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05539729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05539729, "Vancomycin Study in Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05539729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*